TY  - GEN
AU  - Eggermont,Alexander M M
AU  - Blank,Christian U
AU  - Mandala,Mario
AU  - Long,Georgina V
AU  - Atkinson,Victoria G
AU  - Dalle,Stéphane
AU  - Haydon,Andrew
AU  - Lichinitser,Mikhail
AU  - Khattak,Adnan
AU  - Carlino,Matteo S
AU  - Sandhu,Shahneen
AU  - Larkin,James
AU  - Puig,Susana
AU  - Ascierto,Paolo A
AU  - Rutkowski,Piotr
AU  - Schadendorf,Dirk
AU  - Koornstra,Rutger
AU  - Hernandez-Aya,Leonel
AU  - Di Giacomo,Anna Maria
AU  - van den Eertwegh,Alfonsus Jm
AU  - Grob,Jean-Jacques
AU  - Gutzmer,Ralf
AU  - Jamal,Rahima
AU  - Lorigan,Paul C
AU  - Lupinacci,Robert
AU  - Krepler,Clemens
AU  - Ibrahim,Nageatte
AU  - Kicinski,Michal
AU  - Marreaud,Sandrine
AU  - van Akkooi,Alexander C
AU  - Suciu,Stefan
AU  - Robert,Caroline
TI  - Prognostic and predictive value of AJCC-8 staging in the phase III EORTC1325/KEYNOTE-054 trial of pembrolizumab vs placebo in resected high-risk stage III melanoma
SN  - 1879-0852
PY  - 2020///0601
KW  - Adult
KW  - Aged
KW  - Antibodies, Monoclonal, Humanized
KW  - therapeutic use
KW  - Antineoplastic Agents, Immunological
KW  - Disease-Free Survival
KW  - Double-Blind Method
KW  - Female
KW  - Humans
KW  - Male
KW  - Melanoma
KW  - classification
KW  - Middle Aged
KW  - Neoplasm Staging
KW  - methods
KW  - Prognosis
KW  - Skin Neoplasms
KW  - Treatment Outcome
KW  - Melanoma, Cutaneous Malignant
N1  - Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial
UR  - https://doi.org/10.1016/j.ejca.2019.05.020
ER  -